$EYE Cashflow Statement | Understand Stock

$EYE

$15.46 -$0.74 (4.57%) Close

$EYE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Jan 3, 2026	FY2024 12 months to Dec 28, 2024	FY2023 12 months to Dec 30, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Jan 1, 2022
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization
Amortization of debt discount and deferred financing costs
Amortization of cloud computing implementation costs
Asset impairment
Deferred income tax expense (benefit)
Stock-based compensation expense
(Gains) on change in fair value of derivatives
Inventory adjustments
Loss on extinguishment of debt
Other
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Operating lease right of use assets and liabilities
Other assets
Accounts payable
Deferred and unearned revenue
Other liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Purchase of property and equipment
Other
Net cash used for investing activities
Cash flows from financing activities:
Repayments on long-term debt
Borrowings on long-term debt
Payments of debt issuance costs
Payments on finance lease obligations
Proceeds from issuance of common stock
Purchase of treasury stock
Net cash used for financing activities
Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of year
Cash, cash equivalents and restricted cash, end of year (See Note 3)
Supplemental cash flow disclosure information:
Cash paid for interest
Cash paid for taxes
Capital expenditures accrued at the end of the period

Comments